Opposing effects of the HLA-DRB10301-DQB10201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel

Genes and Immunity

Volumn 11, Issue 5, 2010, Pages 423-431

  Benedek, G ^a   Paperna, T ^b   Avidan, N ^b   Lejbkowicz, I ^b   Oksenberg, J R ^c   Wang, J ^c   Brautbar, C ^a,d   Israel, S ^d   Miller, A ^b,e  

^a HEBREW UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Carmel Medical Center   (Ireland)

Author keywords

association studies; autoimmune disease; human leukocyte antigen; major histocompatibility complex; multiple sclerosis; population genetics

Indexed keywords

DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; HLA DQ ANTIGEN; HLA DRB1 ANTIGEN; HLA-DQB1 ANTIGEN; HLA-DRB1*03:01 ANTIGEN;

ADULT; ARAB; ARTICLE; CHRISTIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MOSLEM; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RELIGIOUS GROUP; AGED; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; ISLAM; MIDDLE AGED; RISK;

ADULT; AGED; ARABS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ISLAM; ISRAEL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PREVALENCE; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS;

EID: 77954887352     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.20     Document Type: Article

References (47)

1. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to patho-genesis. Nat Rev Genet 2008; 9: 516-526.
2. Ramagopalan SV, Deluca GC, Degenhardt A, Ebers GC. The genetics of clinical outcome in multiple sclerosis. J Neuro-immunol 2008; 201-202: 183-199.
3. Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007; 61: 228-236.
4. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000; 55: 140-148.
5. Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2008; 105: 13069-13074.
6. Rioux JD, Goyette P, Vyse TJ, Hammarstrom L, Fernando MM, Green T et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA 2009; 106: 18680-18685.
7. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004; 74: 160-167.
8. Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol 2008; 181: 5473-5480.
9. Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T et al. Modification of multiple sclerosis pheno-types by African ancestry at HLA. Arch Neurol 2009; 66: 226-233.
10. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002; 104: 182-191.
11. Marrosu MG, Murru MR, Costa G, Cucca F, Sotgiu S, Rosati G et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and-DR4 alleles. Am J Hum Genet 1997; 61: 454-457.
12. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998; 7: 1235-1237.
13. Grossman I, Avidan N, Singer C, Paperna T, Lancet D, Beckmann JS et al. Genomic profiling of interpopulation diversity guides prioritization of candidate-genes for auto-immunity. Genes Immun 2004; 5: 493-504.
14. Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL et al. The HLA locus and multiple sclerosis in Sicily. Neurology 2005; 64: 361-363.
15. Kallio SP, Jakkula E, Purcell S, Suvela M, Koivisto K, Tienari PJ et al. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS. Hum Mol Genet 2009; 18: 1670-1683.
16. Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y. Epidemiol¬ogy of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 2005; 53: 125-131.
17. Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci 2008; 270: 88-93.
18. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y. Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006; 253: 1210-1216.
19. Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel's diverse populations. Neurology 2006; 66: 1061-1066.
20. Shifman S, Darvasi A. The value of isolated populations. Nat Genet 2001; 28: 309-310.
21. Zalloua PA, Xue Y, Khalife J, Makhoul N, Debiane L, Platt DE et al. Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet 2008; 82: 873-882.
22. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126 (Part 4): 770-782.
23. Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004; 63: 2039-2045.
24. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology 2006; 66: 1235-1240.
25. Daif AK, Al-Rajeh S, Awada A, Al Bunyan M, Ogunniyi A, AbdulJabar M et al. Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features. Eur Neurol 1998; 39: 182-186.
26. Al-Din AS, Khogali M, Poser CM, al-Nassar KE, Shakir R, Hussain J et al. Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palesti¬nians. J Neurol Sci 1990; 100: 137-141.
27. Almawi WY, Busson M, Tamim H, Al-Harbi EM, Finan RR, Wakim-Ghorayeb SF et al. HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs. Clin Diagn Lab Immunol 2004; 11: 770-774.
28. Amar A, Kwon OJ, Motro U, Witt CS, Bonne-Tamir B, Gabison R et al. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum Immunol 1999; 60: 723-730.
29. Sanchez-Velasco P, Karadsheh NS, Garcia-Martin A, Ruiz de Alegria C, Leyva-Cobian F. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations. Hum Immunol 2001; 62: 901-909.
30. Nebel A, Filon D, Weiss DA, Weale M, Faerman M, Oppenheim A et al. High-resolution Y chromosome haplo-types of Israeli and Palestinian Arabs reveal geographic substructure and substantial overlap with haplotypes of Jews. Hum Genet 2000; 107: 630-641.
31. Al-Din AS, Al-Saffar M, Siboo R, Behbehani K. Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens 1986; 27: 196-200.
32. Al-Din AS, el-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A et al. Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995; 131: 144-149.
33. Al-Din ASN, Kurdi A, Mubaidin A, El-Khateeb M, Khalil RW, Wriekat AL. Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Pales¬tinians. J Neurol Sci 1996; 135: 162-167.
34. Al-Shammri S, Nelson RF, Al-Muzairi I, Akanji AO. HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population. Mult Scler 2004; 10: 381-386.
35. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813-2824.
36. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 2009; 74: 17-21.
37. Israel S, Kwon OJ, Weintrob N, Sprecher E, Bloch K, Assa S et al. HLA class II immunogenetics of IDDM in Yemenite Jews. Hum Immunol 1998; 59: 728-733.
38. Mangalam A, Luckey D, Basal E, Behrens M, Rodriguez M, David C. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J Immunol 2008; 180: 7747-7756.
39. Mangalam A, Luckey D, Basal E, Jackson M, Smart M, Rodriguez M et al. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalo-myelitis in HLA-DR3-transgenic mice. J Immunol 2009; 182: 5131-5139.
40. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity\friends or foes? Trends Immunol 2009; 30: 409-414.
41. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B et al. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol 2009; 65: 658-666.
42. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net Tissue Antigens 2003; 61: 403-407.
43. Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Kamika-waji N, Ito H et al. Molecular analysis of HLA class I (HLA-A and-B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens 1998; 52: 539-542.
44. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
45. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
46. Kurtzke JF. Rating neurologic impairment in multiple sclero¬sis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
47. Parzen M, Lipsitz S, Ibrahim J, Klar N. An estimate of the odds ratio that always exists. J Comput Graph Stat 2002; 11: 420-436.